Janku Filip 4
4 · Monte Rosa Therapeutics, Inc. · Filed Sep 13, 2024
Insider Transaction Report
Form 4
Janku Filip
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-09-13+30,000→ 30,000 totalExercise: $7.56Exp: 2032-10-04→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]On October 3, 2022, the Reporting Person was granted an option to purchase 30,000 shares of Common Stock, subject to the satisfaction of certain performance criteria. On September 13, 2024, the performance criteria underlying such shares were met.
- [F2]The shares underlying this option shall vest in full on March 13, 2026, subject to the Reporting Person's continued service on such date.